Moleculin Biotech, Inc. (MBRX) KPIs and segments

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30

$7.87−0.19 (-2.36%)

Close on Nov 13, 2026Market cap $8.23MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Moleculin Biotech's business

Coming soon

This tab will track the numbers specific to Moleculin Biotech's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?